Imipenem: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
imported>Howard C. Berkowitz No edit summary |
||
| Line 1: | Line 1: | ||
'''Imipenem''' is a synthetic broad-spectrum [[antibiotic]], which contains a [[beta-lactam]] ring structure but is not considered a member of the [[penicillin]] or [[cephalosporin]] class, and is not affected by [[beta-lactamase]]s. It is a frequent choice for treatment of infections involving multidrug-resistant bacteria, or multiple types of bacteria. | {{subpages}} | ||
'''Imipenem''' is a synthetic broad-spectrum [[antibiotic]] of the [[carbepenem]] class, which contains a [[beta-lactam]] ring structure but is not considered a member of the [[penicillin]] or [[cephalosporin]] class, and is not affected by [[beta-lactamase]]s. It is a frequent choice for treatment of infections involving multidrug-resistant bacteria, or multiple types of bacteria. Imipenem is derived from the naturally occurring antibiotic thienamycin, which is too unstable for clinical use. | |||
"Its effectiveness is enhanced when it is administered in combination with [[cilistatin]], a renal dipeptidase inhibitor,"<ref>{{MeSH}}</ref> especially when the patient's kidney function is diminished. <ref>{{citation | "Its effectiveness is enhanced when it is administered in combination with [[cilistatin]], a renal dipeptidase inhibitor,"<ref>{{MeSH}}</ref> especially when the patient's kidney function is diminished. <ref>{{citation | ||
Revision as of 10:33, 27 June 2010
Imipenem is a synthetic broad-spectrum antibiotic of the carbepenem class, which contains a beta-lactam ring structure but is not considered a member of the penicillin or cephalosporin class, and is not affected by beta-lactamases. It is a frequent choice for treatment of infections involving multidrug-resistant bacteria, or multiple types of bacteria. Imipenem is derived from the naturally occurring antibiotic thienamycin, which is too unstable for clinical use.
"Its effectiveness is enhanced when it is administered in combination with cilistatin, a renal dipeptidase inhibitor,"[1] especially when the patient's kidney function is diminished. [2]
References
- ↑ Anonymous (2024), Imipenem (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ G A Verpooten, L Verbist, A P Buntinx, L A Entwistle, K H Jones, M E De Broe (1984 August), "The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure.", Br J Clin Pharmacol 18 (2): 183–193